The Clinical and Biometrics Team at Zentalis Pharmaceuticals is dedicated to designing and managing clinical trials while integrating advanced biomarker strategies to evaluate the efficacy and safety of novel cancer therapies. They collaborate closely on data-driven decision-making, employing robust statistical analyses to advance the development of innovative small molecule treatments targeting key biological pathways in oncology.